Acute progression of severe insulin edema accompanied by pericardial and pleural effusion in a patient with type 2 diabetes.
Kawashima
Satoshi
S
Kaneto
Hideaki
H
Sakamoto
Ken'ya
K
Yasuda
Tetsuyuki
T
Kuroda
Akio
A
Shiraiwa
Toshihiko
T
Yamamoto
Kaoru
K
Kasami
Ryuichi
R
Matsuoka
Taka-aki
TA
Yamasaki
Yoshimitsu
Y
Matsuhisa
Munehide
M
D000284:Administration, Oral; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D018450:Disease Progression; D004487:Edema / Q000139:chemically induced* / Q000503:physiopathology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007294:Inositol / Q000031:analogs & derivatives / Q000627:therapeutic use; D007336:Insulin, Isophane / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D010490:Pericardial Effusion / Q000139:chemically induced / Q000503:physiopathology*; D010996:Pleural Effusion / Q000139:chemically induced / Q000503:physiopathology; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D007294:Inositol; D007336:Insulin, Isophane; C057619:glimepiride; C102817:voglibose